Stay updated on Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial page.

Latest updates to the Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2 reference.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.4.2. Removed the previous 'Revision: v3.4.1' notice and the government funding lapse notice.SummaryDifference0.2%

- Check45 days agoChange DetectedA site-wide notice about government funding and operations status was added, and the page version was updated from 3.4.0 to 3.4.1.SummaryDifference0.2%

- Check52 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.3.4 supersedes v3.3.3, indicating a minor page version update with no observed impact on content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check87 days agoChange DetectedExpanded the study's active locations by adding numerous site locations across the United States, Canada, the United Kingdom, Europe, Australia, and Asia, and updated the revision to v3.3.3. This defines the new locations available for enrollment.SummaryDifference3%

Stay in the know with updates to Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial page.